MGC Pharmaceuticals Limited
Stock Forecast, Prediction & Price Target
MGC Pharmaceuticals Limited Financial Estimates
MGC Pharmaceuticals Limited Revenue Estimates
MGC Pharmaceuticals Limited EBITDA Estimates
MGC Pharmaceuticals Limited Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 6/30/2019 | 6/30/2021 | 6/30/2022 | 6/30/2026 | |||
Revenue
% change YoY
| £656.23K N/A | £2.99M 356.55% | £4.73M 57.94% | Avg: £23.88M Low: £23.88M High: £23.88M avg. 404.78% | |||
Net Income
% change YoY
| £-11.00M N/A | £-15.86M -44.14% | £-20.34M -28.21% | Avg: £-58.18M Low: £-58.18M High: £-58.18M avg. -185.93% | |||
EBITDA
% change YoY
| £-8.45M N/A | £-11.59M -37.23% | £-15.40M -32.77% | Avg: £-23.88M Low: £-23.88M High: £-23.88M avg. -55.10% | |||
EPS
% change YoY
| -$9.11 N/A | -$8.33 8.56% | -$7.93 4.80% | Avg: -$19.74 Low: -$19.74 High: -$19.74 avg. -148.93% | |||
Operating Expenses
% change YoY
| £11.52M N/A | £16.63M 44.32% | £21.12M 26.94% | Avg: £101.42M Low: £101.42M High: £101.42M avg. 380.18% | |||
FAQ
What is MGC Pharmaceuticals Limited stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -185.93% in 2026-2026.
We have gathered data from N/A analysts. Their low estimate is -58.18M, average is -58.18M and high is -58.18M.
What is MGC Pharmaceuticals Limited stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 404.78% in 2026-2026.
We have gathered data from N/A analysts. Their low revenue estimate is £23.88M, average is £23.88M and high is £23.88M.
What is MGC Pharmaceuticals Limited stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -148.93% in 2026-2026.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$19.74, average is -$19.74 and high is £-19.74.